ANWAR CHOWDHURY: Open Payments
NPI 1427111715 · SANFORD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,096 in 54 payments from 13 companies in 2025. Trend: 2023 $2,779 · 2024 $2,231 · 2025 $3,096
Food & beverage: $3,096
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $555 |
| ABBVIE INC. | 8 | $421 |
| Alkermes, Inc. | 7 | $407 |
| E.R. Squibb & Sons, L.L.C. | 4 | $364 |
| Otsuka America Pharmaceutical, Inc. | 9 | $344 |
| Teva Pharmaceuticals USA, Inc. | 6 | $303 |
| Vanda Pharmaceuticals Inc. | 3 | $207 |
| Supernus Pharmaceuticals, Inc. | 4 | $143 |
| Janssen Pharmaceuticals, Inc | 1 | $134 |
| Neurocrine BioSciences, Inc. | 1 | $122 |
Products named: CAPLYTA, VRAYLAR, COBENFY, AUSTEDO XR, LYBALVI, REXULTI, FANAPT, ARISTADA.
Industry payments across FL — which companies pay providers there.
